Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Top Cited Papers
- 28 November 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 175 (1) , 17-25
- https://doi.org/10.1016/s0304-3835(01)00718-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Mitochondrion as a Novel Target of Anticancer ChemotherapyJNCI Journal of the National Cancer Institute, 2000
- Acetyl-Boswellic Acids Are Novel Catalytic Inhibitors of Human Topoisomerases I and IIαMolecular Pharmacology, 2000
- Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma CellsJournal of Investigative Dermatology, 2000
- Studies on the Anti-Inflammatory Activity of Rhizomes ofNelumbo nuciferaPlanta Medica, 1997
- Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosisNature Medicine, 1995
- DNA damage, p53 and anticancer therapiesNature Medicine, 1995
- Investigations on the Steroidal Anti-Inflammatory Activity of Triterpenoids fromDiospyros leucomelas*Planta Medica, 1995
- A study of cross‐resistance pattern and expression of molecular markers of multidrug resistance in a human small‐cell lung‐cancer cell line selected with doxorubicinInternational Journal of Cancer, 1993
- Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.Journal of Clinical Investigation, 1993
- Biological and enzymatic features of human melanoma clones with different invasive potentialMelanoma Research, 1992